How these pharmaceuticals may affect otolaryngology
What Is a Biosimilar?
In 1982, the U.S. Food and Drug Administration (FDA) approved the first biologic, a recombinant insulin. Since then, the development and use of biologics has exploded. Between 2011 and 2016, the FDA approved 85 biologics (J Allergy Clin Immunol. 2017;139:1461-1464). Use of biologics—complex, protein-based medical treatments produced by living organisms—continues to grow yearly, and they […]